Every U.S. broker wants China Investment Company as partner.

A laptop by another other name would never smell this sweet.

The globe's female leaders in business, politics and nonprofits.

The biopharma's shares tanked on bad news from its prostate cancer drug, but earlier data could turn that around.

Amylin and Eli Lilly will have to calm investors' fears over its risky diabetes drug.

Women continue to scale the heights of control and influence.

The stars come out in Denver, illuminating critical issues one bus ride at a time.

Data on whether it causes cancer are set to be released next week.

The company's mysterious former executive Mike Quigley is now being talked about as a potential leader.

Chief executive Steve Ballmer's latest attempt at toppling Google is subtle and crafty.

The former-Treasury secretary is given a new position at the bank.

Accounting revisions kept the beleaguered mortgage lender from sinking in the quarter.

The Texas PC-maker is steadily chugging through its turnaround.

Consumer credit problems are a worry across the U.S. these days. In these 10 cities it's a crisis.

The mortgage lender saw its earnings jump in the second quarter, thanks to a helpful accounting revision.

The tanker fight comes to Denver.

Markets off sharply across the board along the Pacific Rim Tuesday on heightened credit fears, after a Credit Suisse report talks of fresh write-downs for the beleagured U.S. insurer.

The London-listed oil and gas explorer provokes jitters on the brink of a buyout deal.

The Federal Housing Administration has been turned into the mortgage industry's lender of last resort. Taxpayer price tag? Maybe $100 billion.

The Federal Housing Administration has been turned into the mortgage industry's lender of last resort. Taxpayer price tag? Maybe $100 billion.